Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

A legfontosabb adatok

Ki végzi
Henry Ford Health System
Hol
Detroit (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
268 fő, tervezett
Kezdés
2026. jan. 28.
Várható befejezés
2030. febr.
A vizsgálat típusa
Beavatkozással járó, 6 csoport
A vizsgált kezelések
  • ENGAGE-ALD Application (APP)
  • Treatment Facilitation bundle
  • Enhanced Usual Care
A regiszteradat frissítve
2026. február 3.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with alcohol-related liver disease who drank alcohol in the past 6 months. They must not have had alcohol use treatment in the past 1 month. Participants are seen at University of Michigan hepatology clinics or are patients in UM Hospitals.

Életkor
18 Years and older
Nem
All
A betegség stádiuma
A documented diagnosis of alcohol-related liver disease (ALD). Any amount of alcohol use within the past 6 months.
Korábbi kezelés
No alcohol use treatment in the past 1 month. This includes counseling, recovery groups such as Alcoholics Anonymous, church support groups, inpatient or intensive outpatient programs, and telehealth versions of these.
Biomarker vagy leletérték
Recent alcohol use can be shown by a positive alcohol test in the medical record, such as blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol. Interview or chart review also counts.

A részvétel fő kizáró okai

  • Serious thinking problems, such as Westhaven grade 2 or higher hepatic encephalopathy (brain changes from liver disease) or a Short Blessed Test score >=10
  • Being evaluated for, listed for, or already having had a liver transplant
  • Unable to read, speak or understand English
  • Already enrolled in the multidisciplinary ALD clinic at Michigan Medicine
  • Past history of not following the rules of earlier clinical or research studies

A regiszter feltételei, szó szerint

Mind a 15 feltétel megnézéseKevesebb

Ki vehet részt

  • Willingness to comply with all study procedures and availability for the duration of the study
  • Willing and able to provide informed consent
  • Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
  • Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
  • Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record
  • No alcohol use treatment within the past 1 month including, but not limited to:; Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use; Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery); Community-based church support groups primarily focused on alcohol abstinence or reduction in use; Residential (inpatient) alcohol treatment; Intensive outpatient programs; Any telehealth version of the above options
  • Access to a Smartphone or computer for purposes of follow-up. Those who do not have a Smartphone will be provided one along with a calling/data plan at no cost to subject by the study team for the duration of the research stud
  • Ability to speak and comprehend English

Ki nem vehet részt

  • Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
  • History of nonadherence to previous clinical or research studies
  • Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score >=10 on the Short Blessed Test for cognitive impairment
  • Any other medical condition or circumstance that precludes safe and meaningful participation in the study
  • Unable to provide voluntary informed consent for any reason
  • Unable to read or understand English
  • Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine

Helyszínek itt: Egyesült Államok

  • Henry Ford HealthDetroit, Egyesült ÁllamokContact: Matthew MelicanRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.

A vizsgálat 6 csoportja

  • Enhanced usual care (EUC)A vizsgált kezelés

    Eligible participants randomized will be given this for stage 1 of treatment (three months) and stage 2 (three months) if participants engaged in alcohol treatment during the first stage of treatment.

    Kezelés: Enhanced Usual Care

  • ENGAGE-ALD application (app)A vizsgált kezelés

    Eligible participants randomized to this arm will be given this for stage 1 (three months) of treatment and stage 2 (three months) if participants engaged in alcohol treatment during the first stage of treatment.

  • ENGAGE-ALD app then Treatment Facilitation BundleA vizsgált kezelés

    Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized and assigned to the Treatment Facilitation bundle for stage 2 (three months).

    Kezelés: ENGAGE-ALD Application (APP) és Treatment Facilitation bundle

  • Enhanced usual care then Treatment Facilitation BundleA vizsgált kezelés

    Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized and assigned to the Treatment Facilitation bundle for stage 2 (three months).

    Kezelés: Treatment Facilitation bundle és Enhanced Usual Care

  • ENGAGE-ALD app then Enhanced usual careA vizsgált kezelés

    Eligible participants randomized to this arm will be given this for stage 1 (three months) of treatment. Participants that are non-responders (did not engage in alcohol treatment) will be re-randomized to the EUC arm stage 2 (three months).

    Kezelés: ENGAGE-ALD Application (APP)

  • Enhanced usual care then Enhanced usual careA vizsgált kezelés

    Eligible participants randomized to this arm will be given this for stage 1 of treatment (three months). Participants that are non-responders (did not engage in alcohol treatment) will be rerandomized to the Enhanced usual care arm stage 2 (three months).

    Kezelés: Enhanced Usual Care

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Enhancing Alcohol Treatment Engagement in ALD Patients
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. február 3.